COVID‐19: Some clinical questions after the first 4 months
Open Access
- 20 June 2020
- journal article
- editorial
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 50 (7) , e13326
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of careJournal of Clinical Virology, 2020
- Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)Clinical Microbiology and Infection, 2020
- Emerging therapies for COVID-19 pneumoniaExpert Opinion on Investigational Drugs, 2020
- The immunology of COVID-19: is immune modulation an option for treatment?The Lancet Rheumatology, 2020
- COVID‐19: Focus on the lungs but do not forget the gastrointestinal tractEuropean Journal of Clinical Investigation, 2020
- Cytokine release syndrome in severe COVID-19Science, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Effective treatment of severe COVID-19 patients with tocilizumabProceedings of the National Academy of Sciences, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the stormEuropean Journal of Clinical Investigation, 2020